Corporate Finance
Merck to acquire Acceleron Pharma: the largest biopharma acquisition of the year
Download PDF Merck & Co. (NYSE: MRK) Market Cap as of 8th October 2021 – $204.10bn Acceleron Pharma, Inc. (NASDAQ: XLRN) Market Cap as of 8th October 2021 – $10.68bn Introduction On Thursday 30th September, Merck & Co.’s acquisition of Acceleron Pharma for a total consideration of about $11.5bn was announced. Merck has agreed Read more…